Page last updated: 2024-11-06

4-aminophthalimide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Aminophthalimide (4-AP) is a fluorescent compound that has gained significant attention for its diverse applications in various fields. Its synthesis typically involves the reaction of phthalic anhydride with ammonia, followed by a subsequent nitration and reduction process. 4-AP exhibits strong fluorescence properties with high quantum yield and excellent photostability, making it suitable for use in fluorescence microscopy, sensing, and bioimaging. Its sensitivity to environmental changes, such as pH and temperature, has led to its utilization in developing fluorescent probes and biosensors. Furthermore, 4-AP derivatives have shown potential as therapeutic agents, demonstrating anticancer and antibacterial activities. The unique structural features and fluorescence properties of 4-AP continue to drive research efforts to explore its potential in various applications, including materials science, biomedicine, and environmental monitoring.'

4-aminophthalimide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72915
SCHEMBL ID372282
MeSH IDM0522446

Synonyms (47)

Synonym
HMS1697C07
BB 0217043
1h-isoindole-1,3(2h)-dione, 5-amino-
nsc25173
4-aminophthalimide
phthalimide, 4-amino-
nsc-25173
1h-isoindole-1, 5-amino-
3676-85-5
5-amino-1h-isoindole-1,3(2h)-dione
AE-641/30105046
5-aminoisoindoline-1,3-dione
5-amino-isoindole-1,3-dione
OPREA1_375068
OPREA1_776359
A0966
AKOS000111809
5-aminoisoindole-1,3-dione
BBL000087
5-amino-2,3-dihydro-1h-isoindole-1,3-dione
STK507132
A823362
EN300-02536
einecs 222-948-6
nsc 25173
BP-11004
FT-0617602
F0907-4240
DTXSID8063127
SCHEMBL372282
5-aminophthalimide
5-amino-1h-isoindole-1,3(2h)-dione #
isoindole, 1,3(2h)-dione, 5-amino-
W-106588
STR03779
citricacid
AC-30018
sr-01000524005
SR-01000524005-1
5-amino-1h-isoindole-1,3(2h)-dione, aldrichcpr
mfcd00041854
Z56795283
BCP18648
CS-0028341
AMY22085
W10834
SY048742
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (6.25)29.6817
2010's13 (81.25)24.3611
2020's2 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.86 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.39 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]